LIMON ZVI 4

4 · CEVA INC · Filed Feb 22, 2021

Form 4

Period: 2021-02-19

Director

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2021-02-19−13,000→ 0 total
Exercise: $30.46Exp: 2021-06-30→ Common Stock (13,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-02-19−26,000→ 0 total
Exercise: $17.61Exp: 2022-06-30→ Common Stock (26,000 underlying)
Exercise/Conversion
Common Stock
2021-02-19$30.46/sh+13,000$395,980→ 37,144 total
Tax Payment
Common Stock
2021-02-19$71.41/sh−5,578$398,325→ 31,566 total
Sale
Common Stock
2021-02-19$71.41/sh−7,422$530,005→ 24,144 total
Exercise/Conversion
Common Stock
2021-02-19$17.61/sh+6,500$114,465→ 30,644 total
Tax Payment
Common Stock
2021-02-19$72.00/sh−1,590$114,480→ 29,054 total
Sale
Common Stock
2021-02-19$72.00/sh−4,910$353,520→ 24,144 total

Footnotes (5)

[F1]Represents a net-exercise of outstanding stock options. The reporting person received 7,422 shares of common stock on the net exercise of an option to purchase 13,000 shares of common stock. The reporting person forfeited 5,578 shares of common stock underlying the option in payment of the exercise price, based on the market price of CEVA common stock at the time of the option exercise on February 19, 2021 of $71.41.
[F2]Represents a net-exercise of outstanding stock options. The reporting person received 4,910 shares of common stock on the net exercise of an option to purchase 6,500 shares of common stock. The reporting person forfeited 1,590 shares of common stock underlying the option in payment of the exercise price, based on the market price of CEVA common stock at the time of the option exercise on February 19, 2021 of $72.00.
[F3]Represents 18,242 shares outstanding and 5,902 unvested RSU's.
[F4]The stock option was granted pursuant to the company's 2003 Director Stock Option Plan.
[F5]The stock option became exercisable as to 25% of the underlying shares on the first year anniversary of the grant date and 25% each year thereafter.

Documents

1 file